Dr. Brian M. Shuch, MD

Dr. Shuch practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Shuch's NPI, 1134370422, was assigned on October 5, 2008. Dr. Shuch graduated from New York University School of Medicine in 2004. Dr. Shuch holds California license A95801.

Dr. Shuch's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Shuch's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Shuch is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Urology. Dmand AI also links Dr. Shuch to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shuch practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Shuch's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Shuch is board certified in urology by the American Board of Urology. Dmand AI has Dr. Shuch's licenses on file in 2 states: California and Connecticut.

Dmand AI lists kidney cysts, kidney removal surgery, urinary endoscopy and UTI among the conditions Dr. Shuch treats.

CMS data shows 479 Medicare services from Dr. Shuch across 7 procedure codes in 2024, for 323 Medicare patients. Medicare paid $74,975 for them.

CMS counts 323 Medicare patients who saw Dr. Shuch in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shuch's median patient age at 65, with 39% women.

In 2024, Dr. Shuch wrote 247 Medicare Part D claims for 70 patients. 81% of them were for generic drugs. CMS names the drug for 171 of them, across 3 drugs with 11 or more claims each, at $31,212 in total drug cost. In 2023, CMS named 103 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Shuch for performance year 2024, reported as part of a group. Dr. Shuch accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Shuch as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 54 papers to Dr. Shuch, published from 2013 to 2025. 2017 was the busiest year, with 7. The most frequent topics are Carcinoma, Renal Cell, Kidney Neoplasms and Genetic Testing. Dr. Shuch has published most often in J Natl Compr Canc Netw. Dr. Shuch's most frequent co-authors are Toni K. Choueiri, MD, Eric Jonasch, MD and Robert J. Motzer, MD.

Dmand AI links Dr. Shuch to 4 clinical trials. 2 are still active or recruiting. Conditions studied include Kidney Neoplasms, Carcinoma, Renal Cell and Urologic Neoplasms. Jonsson Comprehensive Cancer Center sponsors the most, 2.

CMS Open Payments shows 153 general payments to Dr. Shuch from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 35% of the total. Merck Sharp & Dohme Corporation paid the most, $84,259.

Dmand AI lists 1 award for Dr. Shuch, most recently CMS Stage 1 EHR in 2014. Dr. Shuch serves on NCI PDQ Kidney Cancer Board, Society of Urologic Oncology Clinical Trials Consortium and SWOG Genitourinary Cancer Group.

Dr. Shuch graduated from New York University School of Medicine in 2004. Dr. Shuch is a member of AOA, AUA and Society of Urologic Oncology (SUO).

Dr. Shuch is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.